Cvs Health (CVS) EPS (Weighted Average and Diluted) (2009 - 2026)

Cvs Health has reported EPS (Weighted Average and Diluted) for 18 years, with the latest figure at $2.3 in Q1 2026.

• For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) rose 63.12% year-over-year to $2.3; the trailing twelve-month figure through Mar 2026 stood at $2.29 (down 45.48% YoY), and the FY2025 full-year result was $1.39, down 62.02% from the prior year.
• EPS (Weighted Average and Diluted) for Q1 2026 stood at $2.3, down from $2.32 in the prior quarter.
• The five-year high for EPS (Weighted Average and Diluted) was $2.32 in Q4 2025, with the low at -$3.13 in Q3 2025.
• Historically, EPS (Weighted Average and Diluted) has averaged $1.0 across 5 years, with a median of $1.48 in 2023.
• Annual changes were most pronounced in 2023 — EPS (Weighted Average and Diluted) soared 167.57% — and 2025, when it sank 4571.43%.
• Cvs Health's EPS (Weighted Average and Diluted) stood at $1.77 in 2022, then slipped by 10.17% to $1.59 in 2023, then declined by 17.61% to $1.31 in 2024, then surged by 77.1% to $2.32 in 2025, then declined by 0.86% to $2.3 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at $2.3 (Q1 2026), $2.32 (Q4 2025), and -$3.13 (Q3 2025), per Business Quant data.